SMMT

Summit Therapeutics
D

SMMT

13.145
USD
0.72
(5.79%)
قبل الجلسة·12.740USD-0.405(-3.08%)
حجم التداول
288,149
الربح لكل سهم
-1
العائد الربحي
-
P/E
-12
حجم السوق
10,486,418,518
أصول ذات صلة المقالات
المزيد

العنوان: Summit Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.